Specialists

Infographic summarising the July 2026 weekly aspergillosis research update, highlighting new COPD diagnostic criteria for invasive pulmonary aspergillosis, chronic pulmonary aspergillosis serology, ICU galactomannan testing, environmental prevention of fungal disease, and other key research developments.

Weekly Aspergillosis Research Update: COPD IPA Criteria, CPA Serology, ICU Galactomannan and Environmental Prevention

Illustration summarising new research showing allergic bronchopulmonary aspergillosis (ABPA) and Aspergillus sensitisation may be more common in people with chronic obstructive pulmonary disease (COPD).

Weekly Aspergillosis Research Update: June 29

Scientific illustration showing Aspergillus research, antifungal susceptibility testing, therapeutic drug monitoring and clinical management featured in the May 2026 Professional Aspergillosis Update.

Professional Aspergillosis Update: May 2026

Audience: respiratory…

Specialist Evidence Briefing: Aspergillus Serology for CPA Diagnosis: Why Assay Choice, Cut-Offs and Confirmatory Testing Matter

Specialist evidence briefing:…

Commercial Aspergillus fumigatus real-time PCR for invasive pulmonary aspergillosis: specialist evidence briefing

Key message: Commercial…

Research significance summary for specialists: Chronic pulmonary aspergillosis during tuberculosis treatment: emerging evidence, diagnostic pitfalls and implications for TB pathways

Key message: Chronic…